This liposomal formulation of β-Nicotinamide Adenine Dinucleotide (β-NAD⁺) provides a biochemically stabilized powder designed to support cellular metabolism and ATP production. The advanced liposomal delivery system significantly enhances bioavailability, ensuring superior absorption and effective intracellular transport.
Related products: Dihydromyricetin, Magnolol
Liposomal β-Nicotinamide Adenine Dinucleotide (β-NAD⁺) 50% Powder is a high-purity formulation designed to support cellular energy metabolism through the delivery of NAD⁺, an essential coenzyme involved in oxidation-reduction (redox) reactions and energy homeostasis. The incorporation of liposomal encapsulation technology enhances the structural stability of NAD⁺ and promotes its efficient transport across cellular membranes. This formulation is specifically developed to facilitate ATP production, thereby supporting fundamental metabolic functions and cellular vitality.
|
Parameter |
Specification |
|
Molecular Formula |
C₂₁H₂₇N₇O₁₄P₂ |
|
Physical Form |
Powder |
|
Purity |
≥ 95% |
|
Solubility |
Soluble in aqueous media |
|
Stability |
Stable under recommended storage conditions |
|
Packaging |
Sealed in moisture-resistant containers |
Note: The above specifications are based on theoretical parameters and are subject to batch-to-batch variation. Please refer to the certificate of analysis for actual data.
Liposomal β-NAD⁺ 50% Powder is supplied in sealed, moisture-resistant containers to preserve product integrity and prevent degradation. For long-term stability, storage at refrigerated conditions (2–8°C) is recommended. Custom packaging solutions are available upon request to accommodate specific handling, shipping, or bulk requirements.